author-photo

Alan Solomon

University of Tennessee
University of Tennessee Medical Center

238

Papers

9221

Citations

Citation Trend

Filter By

Papers (168) Sort By

Journal Conference Others

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

2021 The New England Journal of Medicine
- Alan Solomon
Show All
- Source
- Cite
- Save
Citations (0)
Management of AL amyloidosis in 2021

2021 Amyloid
- Alan Solomon
Show All
- Source
- Cite
- Save
Citations (0)
One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

2019 Amyloid
Show All
- Source
- Cite
- Save
Citations (20)
Personalizing Amyloidosis Therapy with Real Time PET Imaging of Fibril-Reactive Monoclonal Antibody Cael-101

2018 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis

2017 Blood
Show All
- Source
- Cite
- Save
Citations (14)
Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

2017 Amyloid
Show All
- Source
- Cite
- Save
Citations (39)
Transient M onoclonal Gam mopathy Associated With Cytomegalovirus Infection

2016
Show All
- Source
- Cite
- Save
Citations (0)
Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

2015 Blood
Show All
- Source
- Cite
- Save
Citations (19)
A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.

2015 The Journal of Neuroscience
Show All
- Source
- Cite
- Save
Citations (15)
IgG Conformer's Binding to Amyloidogenic Aggregates.

2015 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (3)